AN2 Therapeutics (ANTX) Enterprise Value (2021 - 2026)
AN2 Therapeutics' (ANTX) quarterly Enterprise Value came in at -$85.3 million in Q1 2026, down 27.18% year-on-year from -$117.1 million in Q1 2025, and down 47.05% on a QoQ basis from -$58.0 million in Q4 2025.
AN2 Therapeutics (ANTX) Enterprise Value (2021 - 2026) Analysis & Trends
AN2 Therapeutics (ANTX) has 6 years of Enterprise Value data on file, last reported at -$85.3 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 27.18% year-over-year to -$85.3 million in Q1 2026; TTM through Mar 2026 was -$85.3 million, a 27.18% decrease from a year earlier, with the FY2025 full-year figure at -$58.0 million, up 30.64% from the prior year.
- Enterprise Value for Q1 2026 stood at -$85.3 million, down from -$58.0 million in the prior quarter.
- Over the last five years, Enterprise Value for ANTX reached as high as -$58.0 million in Q4 2025 and fell as low as -$123.8 million in Q3 2023.
- Historically, Enterprise Value has averaged -$92.8 million across 5 years, with a median of -$95.2 million in 2023.
- Across the five-year window, Enterprise Value tumbled 64.04% in 2022 and surged 41.29% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$96.1 million in 2022, then retreated by 11.7% to -$107.3 million in 2023, then gained by 22.07% to -$83.6 million in 2024, then surged by 30.64% to -$58.0 million in 2025, then sank by 47.05% to -$85.3 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$85.3 million in Q1 2026, -$58.0 million in Q4 2025, and -$61.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | AN2 Therapeutics | 167.57 Mn | 167.57 Mn | - | -85.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.29 Mn |
| Dec 31, 2025 | -58.00 Mn |
| Sep 30, 2025 | -61.92 Mn |
| Jun 30, 2025 | -62.90 Mn |
| Mar 31, 2025 | -67.06 Mn |
| Dec 31, 2024 | -83.62 Mn |
| Sep 30, 2024 | -93.42 Mn |
| Jun 30, 2024 | -104.57 Mn |
| Mar 31, 2024 | -114.22 Mn |
| Dec 31, 2023 | -107.30 Mn |
| Sep 30, 2023 | -123.82 Mn |
| Jun 30, 2023 | -95.25 Mn |
| Mar 31, 2023 | -88.52 Mn |
| Dec 31, 2022 | -96.06 Mn |
| Sep 30, 2022 | -104.38 Mn |
| Jun 30, 2022 | -113.37 Mn |
| Mar 31, 2022 | -118.34 Mn |
| Dec 31, 2021 | -58.56 Mn |